HA
Hansa Biopharma
Seneste kurs
32,08 SEK
22.7.2026
Seneste
36,00 SEK
+12.22%
Opside
3 mdr.
44,50 SEK
+38.72%
Opside
HNSA
3 mdr.+38,72%2 kursmål
6 mdr.+38,72%2 kursmål
1 år+159,51%8 kursmål
Max 8 kursmål
DNB CarnegieDanske Bank
SundhedBiotechnology
Om selskabet
Hansa Biopharma AB is a Swedish biopharmaceutical company developing immunomodulatory enzyme treatments for rare immunological conditions. The company focuses on developing treatments for organ transplantation and autoimmune diseases.
Wikipedia
Tre måneders konsensus
Konsensus
44,50 SEK
Opside
+38,72%
Seneste kurs32,08 SEK
Insiderhandel for Hansa Biopharma
Ingen insiderhandler for den valgte periode.
